GlassScriptPhysician profile
Andrei M Ionescu
NPI 1689604589
$821.15
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.80 · 2021: $407 · 2022: $351.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $187.99 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.84 | 2021-2022 | |
| Daiichi Sankyo INC. | $84.78 | 2021-2022 | |
| Glaxosmithkline, LLC. | $70.02 | 2021-2022 | |
| Pfizer INC. | $62.80 | 2019 | |
| Amgen INC. | $56.40 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.76 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $42.36 | 2021 | |
| Antares Pharma, INC. | $25.53 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.49 | 2022 | |
| Abbvie INC. | $25.30 | 2021 | |
| Nestle Healthcare Nutrition INC. | $24.91 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $20.74 | 2021 | |
| Phadia US INC. | $19.71 | 2022 | |
| Kyowa Kirin, INC. | $19.10 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $17.42 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrei Ionescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.